News

From the opening ceremony: (from left) Jens Peter Holst Lauritsen from Novo Nordisk Foundation, Jørgen Kjems, Kurt V. Gothelf and Ken Howard from iNANO / CEMBID and INANO Center Director, Trolle Linderoth. Photo: Roar Paaske.

2018.03.20 | iNano

Starting signal for the future multifunctional medicine

The potential for the research now being addressed by the Center for Multifunctional Biomolecular Drug Design (CEMBID) at Aarhus University is enormous. The goal is to create a new generation of drugs that can be used to diagnose and treat cancer and atherosclerosis - which together represent two thirds among the causes of death globally.

If you would like to receive our news letter please sign on the link bellow